HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,495,592 | +10.9% | 306,817 | -1.4% | 0.04% | +13.9% |
| Q2 2023 | $31,999,926 | +107113.2% | 311,132 | +13.8% | 0.04% | -2.7% |
| Q1 2023 | $29,847 | +2.3% | 273,475 | +6.7% | 0.04% | -5.1% |
| Q4 2022 | $29,179 | -99.8% | 256,402 | +2.7% | 0.04% | +69.6% |
| Q3 2022 | $15,445,000 | -17.4% | 249,560 | +6.4% | 0.02% | -14.8% |
| Q2 2022 | $18,709,000 | -9.2% | 234,560 | +19.7% | 0.03% | 0.0% |
| Q1 2022 | $20,609,000 | -3.6% | 195,888 | -1.3% | 0.03% | +3.8% |
| Q4 2021 | $21,388,000 | +0.4% | 198,474 | +2.1% | 0.03% | -10.3% |
| Q3 2021 | $21,303,000 | +8.9% | 194,480 | -6.9% | 0.03% | +11.5% |
| Q2 2021 | $19,563,000 | -1.8% | 208,919 | -3.4% | 0.03% | -3.7% |
| Q1 2021 | $19,913,000 | +19.3% | 216,355 | -5.1% | 0.03% | +17.4% |
| Q4 2020 | $16,686,000 | -6.3% | 228,101 | -0.5% | 0.02% | -17.9% |
| Q3 2020 | $17,805,000 | +41.2% | 229,211 | +1.0% | 0.03% | +33.3% |
| Q2 2020 | $12,611,000 | +90.4% | 226,892 | +1.5% | 0.02% | +50.0% |
| Q1 2020 | $6,624,000 | -1.1% | 223,625 | +20.9% | 0.01% | +27.3% |
| Q4 2019 | $6,695,000 | +35.5% | 184,955 | +1.9% | 0.01% | +22.2% |
| Q3 2019 | $4,941,000 | +8.2% | 181,457 | -4.4% | 0.01% | 0.0% |
| Q2 2019 | $4,568,000 | – | 189,857 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |